AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 146 filers reported holding AKEBIA THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $155,000 | -70.9% | 215,881 | -8.3% | 0.00% | -100.0% |
| Q4 2021 | $532,000 | -14.6% | 235,405 | +8.9% | 0.00% | 0.0% |
| Q3 2021 | $623,000 | -25.4% | 216,225 | -1.8% | 0.00% | 0.0% |
| Q2 2021 | $835,000 | +14.2% | 220,205 | +2.0% | 0.00% | 0.0% |
| Q1 2021 | $731,000 | +20.4% | 215,960 | -0.4% | 0.00% | 0.0% |
| Q4 2020 | $607,000 | +11.6% | 216,794 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $544,000 | -79.6% | 216,794 | +10.5% | 0.00% | -80.0% |
| Q2 2020 | $2,665,000 | +97.1% | 196,268 | +10.1% | 0.01% | +66.7% |
| Q1 2020 | $1,352,000 | +18.6% | 178,308 | -1.1% | 0.00% | +50.0% |
| Q4 2019 | $1,140,000 | +58.1% | 180,320 | -2.0% | 0.00% | +100.0% |
| Q3 2019 | $721,000 | -18.1% | 183,963 | +1.2% | 0.00% | -50.0% |
| Q2 2019 | $880,000 | -18.2% | 181,765 | +38.4% | 0.00% | 0.0% |
| Q1 2019 | $1,076,000 | +44.8% | 131,371 | -2.2% | 0.00% | 0.0% |
| Q4 2018 | $743,000 | +8.3% | 134,385 | +73.0% | 0.00% | +100.0% |
| Q3 2018 | $686,000 | -10.9% | 77,672 | +0.7% | 0.00% | -50.0% |
| Q2 2018 | $770,000 | +18.8% | 77,162 | +13.4% | 0.00% | +100.0% |
| Q1 2018 | $648,000 | -38.2% | 68,037 | -3.6% | 0.00% | -50.0% |
| Q4 2017 | $1,049,000 | -25.5% | 70,557 | -1.4% | 0.00% | -33.3% |
| Q3 2017 | $1,408,000 | +49.9% | 71,586 | +9.6% | 0.00% | +50.0% |
| Q2 2017 | $939,000 | +44.2% | 65,342 | -7.6% | 0.00% | +100.0% |
| Q1 2017 | $651,000 | -15.5% | 70,742 | -4.3% | 0.00% | -50.0% |
| Q4 2016 | $770,000 | +11.9% | 73,942 | -2.8% | 0.00% | +100.0% |
| Q3 2016 | $688,000 | +22.0% | 76,042 | +0.9% | 0.00% | 0.0% |
| Q2 2016 | $564,000 | -7.8% | 75,342 | +11.0% | 0.00% | 0.0% |
| Q1 2016 | $612,000 | -1.3% | 67,896 | +41.5% | 0.00% | -50.0% |
| Q4 2015 | $620,000 | +44.9% | 47,987 | +8.3% | 0.00% | +100.0% |
| Q3 2015 | $428,000 | -6.6% | 44,327 | -0.4% | 0.00% | 0.0% |
| Q2 2015 | $458,000 | +182.7% | 44,527 | +206.2% | 0.00% | – |
| Q1 2015 | $162,000 | -4.1% | 14,544 | 0.0% | 0.00% | – |
| Q4 2014 | $169,000 | -47.2% | 14,544 | +0.4% | 0.00% | -100.0% |
| Q3 2014 | $320,000 | -19.4% | 14,482 | +1.3% | 0.00% | 0.0% |
| Q2 2014 | $397,000 | – | 14,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 4,652,561 | $3,340,000 | 5.66% |
| Orchard Capital Management, LLC | 1,762,731 | $1,265,000 | 0.36% |
| Ikarian Capital, LLC | 1,200,000 | $860,000 | 0.11% |
| Ikarian Capital, LLC | 800,000 | $575,000 | 0.08% |
| XTX Topco Ltd | 102,392 | $74,000 | 0.03% |
| Nantahala Capital Management | 965,800 | $693,000 | 0.03% |
| Worth Venture Partners, LLC | 63,500 | $46,000 | 0.02% |
| Ardent Capital Management, Inc. | 43,429 | $31,000 | 0.02% |
| Virtus ETF Advisers LLC | 65,149 | $47,000 | 0.02% |
| RICE HALL JAMES & ASSOCIATES, LLC | 513,292 | $368,000 | 0.02% |